Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers
Clinical trial NCT02034110 · COMPLETED
Trial details
- NCT number
- NCT02034110
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-12
- Primary completion
- 2021-12-10
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.